DENALI ADVISORS LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 198 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
DENALI ADVISORS LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2018$1,0000.0%3300.0%0.00%
Q3 2018$1,0000.0%3300.0%0.00%
Q2 2018$1,0000.0%3300.0%0.00%
Q1 2018$1,0000.0%3300.0%0.00%
Q4 2017$1,0000.0%3300.0%0.00%
Q3 2017$1,0000.0%3300.0%0.00%
Q2 2017$1,0000.0%3300.0%0.00%
Q1 2017$1,0000.0%3300.0%0.00%
Q4 2016$1,0000.0%3300.0%0.00%
Q3 2016$1,0000.0%3300.0%0.00%
Q2 2016$1,0000.0%3300.0%0.00%
Q1 2016$1,0000.0%3300.0%0.00%
Q4 2015$1,000
-50.0%
3300.0%0.00%
Q3 2015$2,0000.0%3300.0%0.00%
Q2 2015$2,000
-99.9%
330
-99.9%
0.00%
-100.0%
Q1 2015$3,165,000
-48.5%
449,930
-43.6%
0.72%
-58.3%
Q4 2014$6,151,000
-1.2%
797,830
-4.2%
1.74%
-3.1%
Q3 2014$6,223,000
+142.0%
833,030
+213.5%
1.79%
+154.5%
Q2 2014$2,572,000265,7300.70%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders